Robex meldet Ergebnisse für das 2. Quartal 2024
QUEBEC CITY, Sept. 01, 2024 (GLOBE NEWSWIRE) -- Robex Resources Inc. („Robex“ oder das „Unternehmen“) (TSXV: RBX) meldet heute die Betriebs- und Finanzergebnisse für das zweite Quartal zum 30. Juni…
Belite Bio, 최고 의학 책임자로 Hendrik P. N. Scholl 박사 선임 발표
안과 분야에서 세계적으로 인정받는 권위자인 Scholl 박사는 스타가르트 질환 관련 사상 최대 규모의 자연사 연구 공동 책임 연구자로도 활동 중 샌디에고, Sept. 02, 2024 (GLOBE NEWSWIRE) -- 임상 단계 바이오…
MiddleGround Capital launches Voluntary Public Takeover Offer for STEMMER IMAGING AG
THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, OR SOUTH AFRICA OR IN…
Ensurge Micropower ASA – Subscription Rights Exercise and Employee Share Purchase Plan
Ensurge Micropower ASA (the "Company") has received notice of exercise of 16,000 vested incentive subscription rights with an exercise price per share of NOK 0.950 from an employee of the…
MiddleGround Capital startet freiwilliges öffentliches Übernahmeangebot für STEMMER IMAGING AG
DIESE MITTEILUNG IST WEDER DIREKT NOCH INDIREKT EIN ANGEBOT IN DEN VEREINIGTEN STAATEN VON AMERIKA, AUSTRALIEN, KANADA, HONGKONG, JAPAN, NEUSEELAND, RUSSLAND, SINGAPUR ODER SÜDAFRIKA ODER IN EINER ANDEREN JURISDIKTION, IN…
Ensurge Micropower ASA – Mandatory Notice of Trade for Primary Insider
Reference is made to the announcement by Ensurge Micropower ASA (the “Company”) today regarding the issue of shares under the Company’s Employee Share Purchase Plan (the “ESPP”), whereby primary insider…
Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
Tokyo, Japan and Cambridge, UK, 2 September 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – announces…
Telecom Cloud Market to Gain USD 126.93 Billion by 2031
Westford, USA, Sept. 02, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Global Telecom Cloud Market will attain a value of USD 126.93 Billion by 2031, with a CAGR of 20%…
Form 8.3 – AXA INVESTMENT MANAGERS: Ascentials plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Belite Bio Mengumumkan Pelantikan Hendrik P. N. Scholl, MD, MA, sebagai Ketua Pegawai Perubatan
Dr. Scholl adalah pemimpin yang diiktiraf di peringkat global dalam bidang oftalmologi dan penyelidik utama penyelaras bagi kajian sejarah semula jadi terbesar bagi penyakit Stargardt. SAN DIEGO,, Sept. 02, 2024…